CIBC Asset Management
TNXP icon

CIBC Asset Management’s Tonix Pharmaceuticals TNXP Stock Holding History

CIBC Asset Management’s Portfolio TNXP Stock Details TNXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-17,568
Closed -$424K – 1426
2025
Q3 		$424K Hold
17,568
– – ﹤0.01% 810
2025
Q2 		$632K Hold
17,568
– – ﹤0.01% 724
2025
Q1 		$314K Buy
+17,568
New +$356K ﹤0.01% 851
2021
Q3 		– Hold
0
– -$14K – 1496
2021
Q2 		– Hold
0
– – – 1362
2021
Q1 		– Hold
0
– – – 1327

Other funds holding TNXP

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $50.9B AUM 42.89% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $4.65B AUM 56.47% 1-Year Est. Return